Telesis Bio Inc EV/EBITDA
Что обозначает EV/EBITDA в Telesis Bio Inc?
EV/EBITDA Telesis Bio Inc является N/A
Какое определение для EV/EBITDA?
EV / EBITDA - это стоимость предприятия, деленная на прибыль до вычета процентов, налогов, обесценивания и амортизации. При помощи неё измеряется, насколько дорогой является акция, и она более действительна для сравнения компаний, чем для соотношения цены и прибыли. Она измеряет цену (в форме стоимости предприятия), которую инвестор платит в пользу денежного потока компании (в форме EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA компаний в Health Care сектор на NASDAQ по сравнению с Telesis Bio Inc
Что делает Telesis Bio Inc?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Компании с ev/ebitda похож на Telesis Bio Inc
- Ximen Mining имеет EV/EBITDA из N/A
- Rebel Capital 2.0 имеет EV/EBITDA из N/A
- Hong Kong Johnson Hldg Co Ltd имеет EV/EBITDA из N/A
- VOTI Detection имеет EV/EBITDA из N/A
- Lift & Co имеет EV/EBITDA из N/A
- Novatti имеет EV/EBITDA из N/A
- Telesis Bio Inc имеет EV/EBITDA из N/A
- In8 Bio имеет EV/EBITDA из N/A
- Nitin Fire Protection Industries имеет EV/EBITDA из N/A
- Renalytix AI plc имеет EV/EBITDA из N/A
- Sunmirror Ag Sf 1 имеет EV/EBITDA из N/A
- Sinotruk (Hong Kong) имеет EV/EBITDA из N/A
- Cross River Ventures имеет EV/EBITDA из N/A